European Heart Journal Advance Access published online on January 25, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi114
1 Department of Medicine, University of Melbourne, Austin Health, Repatriation Heidelberg Hospital, Heidelberg 3081, Victoria, Australia
* To whom correspondence should be addressed. Aims Angiotensin converting enzyme (ACE) 2 catalyses the cleavage of angiotensin (Ang) I to Ang 1-9 and of Ang II to Ang 1-7. ACE2 deficiency impairs cardiac contractility and upregulates hypoxia-induced genes, suggesting a link with myocardial ischaemia. We studied the expression of ACE2 after myocardial infarction (MI) in the rat as well as in human failing hearts. Methods and results Rats were killed at days 1, 3, and 28 after MI, or treated for 4 weeks with the ACE inhibitor ramipril (1 mg/kg). Cardiac gene and protein expression of ACE and ACE2 were assessed by quantitative real-time reverse transcriptase-polymerase chain reaction and immunohistochemistry/activity assays/in vitro autoradiography, respectively. Both ACE (P = 0.022) and ACE2 (P = 0.015) mRNA increased in the border/infarct area compared with the viable area at day 3 after MI. By day 28, increases in ACE (P = 0.005) and ACE2 (P = 0.006) mRNA were also seen in the viable myocardium of MI rats compared with myocardium of control rats. ACE2 protein localized to macrophages, vascular endothelium, smooth muscle, and myocytes. Ramipril attenuated cardiac hypertrophy and inhibited cardiac ACE. In contrast, ramipril had no effect on cardiac ACE2 mRNA, which remained elevated in all areas of the MI rat heart. Immunoreactivity of both ACE and ACE2 increased in failing human hearts. Conclusion The increase in ACE2 after MI suggests that it plays an important role in the negative modulation of the renin angiotensin system in the generation and degradation of angiotensin peptides after cardiac injury.
Preclinical research
Myocardial infarction increases ACE2 expression in rat and humans
2 Heart Failure and Transplant Unit, St Vincent's Hospital, Darlinghurst, Sydney, New South Wales, Australia
3 Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Australia
Louise M. Burrell, E-mail: l.burrell{at}unimelb.edu.au
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. H. Zucker, H. D. Schultz, K. P. Patel, W. Wang, and L. Gao Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1557 - H1566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Kassiri, J. Zhong, D. Guo, R. Basu, X. Wang, P. P. Liu, J. W. Scholey, J. M. Penninger, and G. Y. Oudit Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction Circ Heart Fail, September 1, 2009; 2(5): 446 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. W. Lai, R. A. Lew, M. A. Yarski, F.-T. Mu, R. K. Andrews, and A. I. Smith The Identification of a Calmodulin-Binding Domain within the Cytoplasmic Tail of Angiotensin-Converting Enzyme-2 Endocrinology, May 1, 2009; 150(5): 2376 - 2381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Soler, M. Ye, J. Wysocki, J. William, J. Lloveras, and D. Batlle Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan Am J Physiol Renal Physiol, February 1, 2009; 296(2): F398 - F405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Greenberg An ACE in the Hole: Alternative Pathways of the Renin Angiotensin System and Their Potential Role in Cardiac Remodeling J. Am. Coll. Cardiol., August 26, 2008; 52(9): 755 - 757. [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Femia, K. P. Maresca, S. M. Hillier, C. N. Zimmerman, J. L. Joyal, J. A. Barrett, O. Aras, V. Dilsizian, W. C. Eckelman, and J. W. Babich Synthesis and Evaluation of a Series of 99mTc(CO)3+ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression J. Nucl. Med., June 1, 2008; 49(6): 970 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Guy, D. W. Lambert, A. J. Turner, and K. E. Porter Functional angiotensin-converting enzyme 2 is expressed in human cardiac myofibroblasts Exp Physiol, May 1, 2008; 93(5): 579 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Lew, F. J. Warner, I. Hanchapola, M. A. Yarski, J. Manohar, L. M. Burrell, and A. I. Smith Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor Exp Physiol, May 1, 2008; 93(5): 685 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Burchill, E. Velkoska, R. G. Dean, R. A. Lew, A. I. Smith, V. Levidiotis, and L. M. Burrell Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression Exp Physiol, May 1, 2008; 93(5): 622 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Der Sarkissian, J. L. Grobe, L. Yuan, D. R. Narielwala, G. A. Walter, M. J. Katovich, and M. K. Raizada Cardiac Overexpression of Angiotensin Converting Enzyme 2 Protects the Heart From Ischemia-Induced Pathophysiology Hypertension, March 1, 2008; 51(3): 712 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Y. Oudit, Z. Kassiri, M. P. Patel, M. Chappell, J. Butany, P. H. Backx, R. G. Tsushima, J. W. Scholey, R. Khokha, and J. M. Penninger Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice Cardiovasc Res, July 1, 2007; 75(1): 29 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Backlund, P. Lakkisto, E. Palojoki, T. Gronholm, A. Saraste, P. Finckenberg, E. Mervaala, I. Tikkanen, and M. Laine Activation of protective and damaging components of the cardiac renin-angiotensin system after myocardial infarction in experimental diabetes Journal of Renin-Angiotensin-Aldosterone System, June 1, 2007; 8(2): 66 - 73. [Abstract] [PDF]
|
|
|
|
 |
|
 A.-J. Liu, X.-J. Ma, F.-M. Shen, J.-G. Liu, H. Chen, and D.-F. Su Arterial Baroreflex: A Novel Target for Preventing Stroke in Rat Hypertension Stroke, June 1, 2007; 38(6): 1916 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Trask, D. B. Averill, D. Ganten, M. C. Chappell, and C. M. Ferrario Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3019 - H3024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Keidar, M. Kaplan, and A. Gamliel-Lazarovich ACE2 of the heart: From angiotensin I to angiotensin (1-7) Cardiovasc Res, February 1, 2007; 73(3): 463 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Diez-Freire, J. Vazquez, M. F. Correa de Adjounian, M. F. R. Ferrari, L. Yuan, X. Silver, R. Torres, and M. K. Raizada ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR Physiol Genomics, January 12, 2007; 27(1): 12 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Ocaranza, I. Godoy, J. E. Jalil, M. Varas, P. Collantes, M. Pinto, M. Roman, C. Ramirez, M. Copaja, G. Diaz-Araya, et al. Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat Hypertension, October 1, 2006; 48(4): 572 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wysocki, M. Ye, M. J. Soler, S. B. Gurley, H. D. Xiao, K. E. Bernstein, T. M. Coffman, S. Chen, and D. Batlle ACE and ACE2 Activity in Diabetic Mice. Diabetes, July 1, 2006; 55(7): 2132 - 2139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Grobe, A. P. Mecca, H. Mao, and M. J. Katovich Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2417 - H2423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Danilczyk and J. M. Penninger Angiotensin-Converting Enzyme II in the Heart and the Kidney Circ. Res., March 3, 2006; 98(4): 463 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Paizis, C Tikellis, M E Cooper, J M Schembri, R A Lew, A I Smith, T Shaw, F J Warner, A Zuilli, L M Burrell, et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2 Gut, December 1, 2005; 54(12): 1790 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Ferrario, A. J. Trask, and J. A. Jessup Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2281 - H2290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Haulica, W. Bild, and D. N Serban Review: Angiotensin Peptides and their Pleiotropic Actions Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 121 - 131. [Abstract] [PDF]
|
|
|
|
 |
|
 L. M. Burrell, M. E. Cooper, and C. I. Johnston Myocardial infarction increases ACE2 expression in rat and humans: reply Eur. Heart J., June 1, 2005; 26(11): 1142 - 1143. [Full Text] [PDF]
|
|
|
|
|
|
L. S. Zisman Myocardial infarction increases ACE2 expression in rat and humans: reply Eur. Heart J., June 1, 2005; 26(11): 1141 - 1142. [Full Text] [PDF]
|
|
|
|
|
|
L. S. Zisman ACE and ACE2: a tale of two enzymes Eur. Heart J., February 2, 2005; 26(4): 322 - 324. [Full Text] [PDF]
|
|